氨溴索联合布地奈德治疗新生儿肺炎的药理分析

Pharmacological Analysis of Ambroxol Combined With Budesonide in the Treatment of Neonatal Pneumonia

目的探究氨溴索联合布地奈德对治疗新生儿肺炎的药理分析及效果。方法选取2018年4月—2019年4月期间收治的58例新生儿肺炎,按照治疗方式的不同将其分为对照组29例,实施常规新生儿肺炎的治疗措施联合布地奈德吸入治疗。质量组29例,在对照组的基础上增加使用氨溴索联合布地奈德吸入治疗,观察并对比两组患儿的治疗效果。结果治疗组患儿在治疗有效率上要显著优于对照组患儿(P<0.05),且治疗组患儿临床症状消退(退热时间、肺部啰音消除时间、呼吸急促缓解时间等)的时间要早于对照组患儿(P <0.05)。讨论在新生儿肺炎的治疗中,通过使用氨溴索联合布地奈德吸入治疗,治疗效果显著,有效的提升了治疗有效率以及新生儿的肺部功能。

Objective To explore the pharmacological analysis and effect of ambroxol combined with budesonide in the treatment of neonatal lung.Methods 58 cases of neonatal pneumonia admitted from April 2018 to April 2019 were divided into control group(29 cases)according to different treatment methods.The routine treatment of neonatal pneumonia combined with budesonide inhalation therapy was implemented.29 cases in the quality group were treated with ambroxol combined with budesonide inhalation on the basis of the control group.The therapeutic effects of the two groups were observed and compared.Results The effective rate of the treatment group was significantly better than that of the control group(P<0.05),and the clinical symptoms of the treatment group disappeared earlier than those of the control group(fever abatement time,lung rale elimination time,shortness of breath relief time,etc.)(P<0.05).Conclusion In the treatment of neonatal pneumonia,the use of ambroxol combined with budesonide inhalation treatment,the treatment effect is remarkable,effectively improve the treatment efficiency and neonatal pulmonary function.